I
UTHR icon

InceptionR’s United Therapeutics UTHR Stock Holding History

InceptionR’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,280
Closed -$368K – 951
2025
Q2 		$368K Buy
+1,280
New +$383K 0.09% 390
2024
Q3 		– Sell
-2,196
Closed -$700K – 885
2024
Q2 		$700K Buy
+2,196
New +$581K 0.2% 196
2023
Q4 		– Sell
-2,749
Closed -$621K – 533
2023
Q3 		$621K Buy
+2,749
New +$633K 0.35% 99
2023
Q2 		– Sell
-2,990
Closed -$670K – 618
2023
Q1 		$670K Buy
2,990
+630
+27% +$155K 0.21% 182
2022
Q4 		$656K Buy
+2,360
New +$596K 0.35% 98

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

InceptionR's UTHR Position: Q3 2025 in Review

InceptionR sold out of United Therapeutics (UTHR) in Q3 2025, closing a stake of 1,280 shares — an estimated $368K sold.

InceptionR first reported a position in UTHR in Q4 2022 and held it in 5 quarters. The position peaked at $700K in Q2 2024. 708 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • InceptionR reported no remaining United Therapeutics position as of Q3 2025 after selling out during the quarter.
  • InceptionR sold 1,280 United Therapeutics shares in Q3 2025, an estimated $368K.
  • InceptionR first reported a position in United Therapeutics in Q4 2022 and held it in 5 quarters.
  • InceptionR's United Therapeutics position peaked at $700K in Q2 2024.
  • 708 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on InceptionR's 13F filing for Q3 2025, filed 13 Nov 2025.